Jump to resource

Projects. Life and Matter Sciences

Metabolism and cancer

17th National Programme

The oncogenic function of IF1: the inhibitor of mitochondrial  H+-ATP syntase
Lead Researcher: José Manuel Cuezva Marcos
Research Centre: Centro de Biología Molecular Severo Ochoa. CSIC-UAM.

Pharmaco-mimetic analysis of the therapeutic value of Vav-dependent metabolic routes in breast cancer
Lead Researcher: Xosé Ramón García Bustelo
Research Centre: Centro de Investigación del Cáncer de Salamanca.

The antitumor effect of GCN2 kinase: the relationship between nutritional stress, protein synthesis and skin cancer
Lead Researcher: César Jesús de Haro Castella
Research Centre: Centro de Biología Molecular Severo Ochoa. CSIC-UAM.

Oxidise NADPH and the regulation of intermediate leukemic cell metabolism: the search for new therapeutic strategies
Lead Researcher: Ángel Hernández Hernández
Research Centre: Instituto de Investigación Biomédica de Salamanca (IBSAL). CSIC-Universidad de Salamanca.

Inhibition of the protein that regulates SLC4A2 cell ion metabolism as a new therapy in leukaemia, lymphoma and myeloma
Lead Researcher: José Ángel Martínez-Climent
Research Centre: Centro de Investigación Médica Aplicada de la Universidad de Navarra. Pamplona.

Studies of tumorigenesis in Drosophila: possible clinical implications
Lead Researcher: Ginés Morata Pérez
Research Centre: Centro de Biología Molecular Severo Ochoa. CSIC-UAM.

The diagnosis of cancer by means of a metabolic nanosensor platform
Lead Researcher: Ángel Orte Gutiérrez
Research Centre: Facultad de Farmacia. Universidad de Granada.

The inhibition of fatty acid syntase lipogenic enzyme (FASN) as a new therapeutic strategy for the treatment of triple negative breast cancer
Lead Researcher: Teresa Puig Miquel
Research Centre: Facultad de Medicina. Universidad de Girona.

The AMPK enzyme, a nexus joined metabolism and cancer. A new therapeutic strategy in cerebral glyoblastomas
Lead Researcher: Rosa Mª Señarís Rodríguez
Research Centre: Departamento de Fisiología. CIMUS. Universidad de Santiago de Compostela.

The effect of antitumour penetrating peptides based on connexin-43 in the selective metabolic reprogramming of human glyoma stem cells
Lead Researcher: Aránzazu Tabernero Urbieta
Research Centre: Instituto de Neurociencias de Castilla y León. Universidad de Salamanca.

Molecular characterisation of the role of mitochondrial dysfunction in tumoral development
Lead Researcher: Ignacio Alejandro Varela Egocheaga
Research Centre: Instituto de Biomedicina y Biotecnología de Cantabria. CSIC-Universidad de Cantabria-SODERCAN.

Síguenos en

  • Twitter
  • Facebook
  • Flickr
  • Youtube
  • Slideshare

© 2007 Fundación Ramón Areces All rights reserved.

c/ Vitruvio, 5. 28006 Madrid (España) | Telephone: 91 515 89 82 | C.I.F.: G-28459311